-

Life Spine Announces FDA 510(k) Clearance for the PLATEAU®-X Ti Lateral Lumbar Spacer System

HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the PLATEAU-X Ti Lateral Lumbar Spacer System.

“The launch of PLATEAU-X Ti furthers our commitment of offering micro invasive solutions that are designed to save time, save money, and accelerate patient recovery,” said Mariusz Knap, Sr. Vice President of Sales and Marketing for Life Spine. “PLATEAU-X Ti and all of our titanium implants offer a proprietary surface treatment, Osseo-Loc™. PLATEAU-X Ti improves our already extensive lateral portfolio comprised of PROLIFT® Lateral Expandable Spacer System, CENTRIC® Plier-Style Retractor, and SENTRY® Lateral Plating Systems.”

The PLATEAU-X Ti Lateral Lumbar Spacer enables surgeons to effectively provide anterior column support through a lateral approach. The PLATEAU-X Ti Lateral Lumbar Spacer incorporates a comprehensive set of instruments and implants to streamline the surgical procedure.

Key Features and Benefits:

• Self-distracting leading edge to ease implant insertion

• Osseo-Loc™ Titanium Surface Treatment Technology

• Available in 0˚, 7˚ and 15˚ lordosis: 40, 45, 50, 55 and 60mm lengths: 8 - 16mm heights: 18, 22 and 26mm widths

• Convex design maximizes vertebrae endplate contact for ideal patient fit

• Large, open graft windows for maximum visibility and bone graft containment

About Life Spine

Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit: http://www.lifespine.com and/or https://www.micro-invasive.com.

Contacts

Mr. Omar Faruqi
Chief Financial Officer
ofaruqi@lifespine.com
847-884-6117

Industry:

Life Spine

Release Versions
English

Contacts

Mr. Omar Faruqi
Chief Financial Officer
ofaruqi@lifespine.com
847-884-6117

More News From Life Spine

Life Spine Files Lawsuit Against Former CEO Michael Butler for Breaches of Fiduciary Duties and Contracts, Trade Secret Misappropriation, and Tortious Interference

HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, Inc., a leading medical device company specializing in spinal surgery innovations, announced today that it has filed a lawsuit in the Circuit Court of Cook County, Illinois, against its former Chief Executive Officer, Michael Butler. In the lawsuit, Life Spine alleges that Mr. Butler wrongfully diverted hundreds of thousands of dollars from the company through a sham importer entity he controlled and funded with Life Spine resources, directed the comp...

Life Spine, Inc. Appoints Richard Mueller as President & Chief Executive Officer

HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, Inc., a leading medical device company specializing in the design, development, and manufacturing of innovative products for the surgical treatment of spinal disorders, announces Richard Mueller as its new President & Chief Executive Officer (CEO). Mr. Mueller joined Life Spine, Inc. in 2015 as Chief Operating Officer (COO), bringing with him over 30 years of experience in the medical device industry. Prior to his tenure at Life Spine, Inc., he he...

Life Spine Announces First Surgical Cases of ARx® SAI Spinal Fixation System

HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the first surgical cases of ARx SAI (Sacral Alar Iliac) Spinal Fixation System. The ARx SAI Spinal Fixation System represents the next evolution in posterior fixation technology. Designed for optimal stabilization, the ARx SAI system can be utilized through a Sacral Alar Iliac trajectory within the S1...
Back to Newsroom